ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ANIX vs IMUX // ENTERPRISE SCALE & MARKET CAP

Anixa Biosciences Inc. (NASDAQ) VS. Immunic Inc. (NASDAQ) • 15-METRIC TALLY: ANIX 3 — IMUX 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ANIX
market-cap
$103.9M
market-cap
$100.2M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIX VS. IMUX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ANIX IMUX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.25% — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 ANIX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.9 38.5 +12.40 ANIX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $103.9M $100.2M $3.8M ANIX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ANIX REV IMUX REV ANIX GROSS % IMUX GROSS % ANIX FCF IMUX FCF
FY 2025 $32.8M $289.0M — — -$7.2M -$86.0M
FY 2024 $210.0K $274.5M — — -$7.3M -$85.0M
FY 2023 $210.0K $277.8M — — -$6.2M -$70.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIX // BETA —
IMUX // BETA —